Neoadjuvant Chemotherapy in Patients with HER2-Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.

Although these differences did not reach statistical significance, the consistency of TAC’s performance across multiple outcome measures cannot be overlooked.

also in 111,027 other papers